Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Zymergen
company
About
Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.
- 501 - 1000
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $130M
- Industries
- Artificial Intelligence,Big Data,Bioinformatics,Biotechnology,Machine Learning,Robotics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$130M
Zymergen has raised a total of
$130M
in funding over 2 rounds. Their latest funding was raised on
Oct 11, 2016 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 11, 2016 | Series B | $130M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Zymergen is funded by 1 investors.
Prelude Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Prelude Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
